Mark S Soloway, MD

Soloway Mark S
Urologic Oncology, Urology

Primary Office
20801 Biscayne Blvd
Ste 203
Aventura, FL 33180
Alternate Location
900 Glades Road
Ste 500
Boca Raton, FL 33431

Meet the Physician

Chief of Urologic Oncology

Dr. Mark Soloway is a board-certified urologist and an internationally recognized leader in urologic oncology who has made significant contributions to the understanding and treatment of prostate, bladder and kidney cancer over a 40-year career. He earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio, and completed his residency in urology at University Hospitals of Cleveland. He completed his surgery branch fellowship at the National Cancer Institute of the National Institutes of Health in Bethesda, Maryland.

Dr. Soloway has contributed to the field of education with his innovative use of case-based teaching. He served as professor and chairman at the University of Miami Miller School of Medicine’s Department of Urology from 1991 until 2010.

Because of his expertise in the field of bladder cancer, he has twice been asked to chair the International Consultation on Urologic Diseases Recommendation Panel on Bladder Cancer (2004 and 2011), a committee charged with making recommendations on all aspects of bladder cancer.

Dr. Soloway has published more than 500 articles in peer-reviewed journals and has lectured extensively, both in the United States and around the world.



Awards and honors

  • St. Paul’s Medal, British Association of Urological Surgeons (BAUS), 2015
  • Whitmore Memorial Lecture, Society of Urologic Oncology, 2014
  • Lifetime Achievement Award, International Urology Society, 2013
  • Doctor Honoris Causa, University of Athens School of Medicine, 2012
  • Presidential Citation, American Urologic Association, 2008
  • Gold Cystoscope Award, American Urologic Association, 1984
  • More than 50 Visiting Professorships
  • Phi Beta Kappa
  • AOA, Junior year
  • North Central Section of the American Urological Association Traveling Fellowship Award, 1972-73

Professional organizations

  • American Urological Association
  • American Association of Genitourinary Surgeons (AAGUS)
  • Southeastern Section, American Urologic Association
  • American Society of Clinical Oncology
  • American Association of Cancer Research
  • Fellow American College of Surgeons (FACS)
  • Urological Research Society
  • Society of Urologic Oncology
  • German Urology Association (honorary member)
  • Dutch Urologic Society (honorary member)
  • Buffalo Urologic Society (honorary member)

Selected publications

  • “Radical Nephrectomy with Inferior Vena Cava Tumor Thrombectomy,” Atlas of Operative Surgery, 2013
  • “Legends of Urology,” The Canadian Journal of Urology, 2009

Prostate Cancer

  • “Active Surveillance for Prostate Cancer: A Systematic Review of the Literature,” European Urology, 2012
  • “Factors That Influence Patient Enrollment in Active Surveillance for Low-Risk Prostate Cancer,” Urology, 2011
  • “Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment,” European Urology, 2010
  • “A Multi-Institutional Evaluation of Active Surveillance for Low-Risk Prostate Cancer,” Journal of Urology, 2009
  • “Active Surveillance: A Reasonable Management Alternative for Patients with Prostate Cancer: The Miami Experience,” BJU International, 2008
  • “Modified Pfannenstiel Approach for Radical Retropubic Prostatectomy: A Three-Year Experience,” Prostate Cancer and Prostatic Diseases, 2008
  • “Prostate Specific Antigen Recurrence Rates Are Low After Radical Retropubic Prostatectomy and Positive Margins,” Journal of Urology, 2006
  • “Concurrent Radical Retropubic Prostatectomy and Lichtenstein Inguinal Hernia Repair Through a Single Modified Pfannenstiel Incision: A Three-Year Experience,” BJU International, 2006
  • “Sexual, Psychological and Dyadic Qualities of the Prostate Cancer ‘Couple,’” BJU International, 2005
  • “Modified Pfannenstiel Approach for Radical Retropubic Prostatectomy,” Urology, 2004
  • “Where Are the ‘Poster Boys’ for Bladder Cancer?”, BJU International, 2003
  • “Do Unto Others – Why I Would Want Anesthesia for My Prostate Biopsy,” Urology, 2003
  • “Timing of Androgen Deprivation for Prostate Cancer: Benefits Versus Side Effects – A Patient-Physician Dialogue,” Urology, 2002
  • “Periprostatic Local Anesthesia Before Ultrasound Guided Prostate Biopsy,” Journal of Urology, 2000
  • “Incidence, Etiology, Location, Prevention and Treatment of Positive Surgical Margins After Radical Prostatectomy for Prostate Cancer,” Journal of Urology, 1998
  • “Androgen Deprivation Prior to Radical Prostatectomy for T2b and T3 Prostate Cancer,” Urology, 1994
  • “Adenocarcinoma of the Prostate: Stage-by-Stage Treatment Alternatives,” Postgraduate Medicine, 1988

Bladder Cancer

  • “International Consultation on Bladder Cancer 2012” Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder,” European Urology, 2012
  • “Diagnosis and Treatment of Bladder Cancer: How Can We Improve?”, Postgraduate Medicine, 2012
  • “Radical Cystectomy for Urothelial Carcinoma of the Bladder: An Analysis of Perioperative and Survival Outcome,” BJU International, 2009
  • “Complete Transurethral Resection of Bladder Tumor: Are the Guidelines Being Followed?”, Urology, 2009
  • “Bladder Cancer after Radiotherapy for Prostate Cancer: Detailed Analysis of Pathological Features and Outcome after Radical Cystectomy,” Journal of Urology, 2008
  • “Secondary Cancer after Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?”, European Urology, 2007
  • “Radical Cystectomy after Bacillus Calmette-Guerin for High-Risk Ta, T1 and Carcinoma In Situ: Defining the Risk of Initial Bladder Preservation,” Urology, 2006
  • “Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder Tumors,” Journal of Urology, 2003
  • “Contemporary Management of Stage T1 Transitional Cell Carcinoma of the Bladder,” Journal of Urology, 2002
  • “Incorporation of M-VAC Combination Chemotherapy in the Treatment of Patients with Invasive and Metastatic Bladder Cancer,” European Urology, 1988
  • “Treatment of Invasive Bladder Cancer by Cisplatin and Radiation in Patients Unsuited for Surgery,” Journal of the American Medical Association, 1987
  • “Flexible Cystourethroscopy: Alternative to Rigid Instruments for Evaluation of Lower Urinary Tract,” Urology, 1985
  • “Bladder Cancer: Management of an Increasingly Common Tumor,” Postgraduate Medicine, 1983

Kidney Cancer

  • “Liver Transplantation Techniques for the Surgical Management of Renal Cell Carcinoma with Tumor Thrombus in the Inferior Vena Cava: Step-by-Step Description,” European Urology, 2011
  • “Long-Term Survival in Patients Undergoing Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Single-Center Experience,” European Urology, 2010
  • “Surgical Management of Renal Cell Carcinoma with Tumor Thrombosis in the Renal and Inferior Vena Cava: The University of Miami Experience in Using Liver Transplantation Techniques,” European Urology, 2007
  • “The Use of Liver Transplant Techniques to Aid in the Surgical Management of Urological Tumors,” Journal of Urology, 2000


  • Case Western Reserve School Of Medicine, 1968
  • University Hospital Of Cleveland, 1970, Surgery
  • American Board of Urology-Urology